[HTML][HTML] Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - Scientific Reports, 2017 - nature.com
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sanchez-Carrillo, I Mate-Cano… - 2017 - repisalud.isciii.es
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sanchez-Carrillo, I Mate-Cano… - 2017 - lareferencia.info
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: A cross-sectional study
C Palladino, M Sánchez-Carrillo, I Maté-Cano… - Scientific …, 2017 - repositorio.ul.pt
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
Low frequency of NS5A relevant resistance-associated substitutions to elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study.
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - 2017 - cabidigitallibrary.org
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
[PDF][PDF] Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - core.ac.uk
Results Of 632 patients included in this study, 13 samples (2.1%) were excluded because
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
[PDF][PDF] Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - academia.edu
Results Of 632 patients included in this study, 13 samples (2.1%) were excluded because
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
[HTML][HTML] Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - Scientific …, 2017 - ncbi.nlm.nih.gov
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
[PDF][PDF] Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo, I Mate-Cano… - researchgate.net
Results Of 632 patients included in this study, 13 samples (2.1%) were excluded because
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
HCV RNA could not be amplified or we were unable to achieve a HCV sequence consensus …
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
C Palladino, M Sánchez-Carrillo… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …
inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients …